Protagonist Therapeutics Aktie
47,20
EUR
±0,00
EUR
±0,00
%
51,10
USD
-1,48
USD
-2,81
%
Werbung
Protagonist Therapeutics Aktie Analyse
08.07.19 | Protagonist Therapeutics Buy | H.C. Wainwright & Co. | |
22.02.19 | Protagonist Therapeutics Outperform | BMO Capital Markets | |
29.01.18 | Protagonist Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
21.07.17 | Protagonist Therapeutics Buy | BTIG Research | |
06.09.16 | Protagonist Therapeutics overweight | Barclays Capital |
Werbung
Werbung